Literature DB >> 15609243

Unique characteristics of the intestinal immune system as an inductive site after antigen reencounter.

Anu Kantele1, Heikki Arvilommi, Katja Iikkanen, Erkki Savilahti, Helena P Mäkelä, Christian Herzog, Emil Fürer, Jussi M Kantele.   

Abstract

BACKGROUND: Immunization prepares the body for a reencounter with the microbe. Information on the targeting of immune effector cells during secondary immune response--that is, lymphocyte homing--is scarce. In the present study, the homing potentials of lymphocytes are examined after antigen reencounter at mucosal versus nonmucosal sites.
METHODS: Orally or parenterally immunized volunteers were reimmunized orally or parenterally with Salmonella typhi Ty21a, and the expression of the gut homing receptor (HR), alpha(4)beta(7), and of the peripheral lymph node HR, L-selectin, was investigated in circulating antigen-specific antibody-secreting cells (ASCs). Lymphocytes were sorted by HR expression and examined for antibody production, by use of an enzyme-linked immunospot assay.
RESULTS: After oral reimmunization, 90% of ASCs were alpha(4)beta(7) positive and 88% were L-selectin positive, an expression profile that differed significantly from that found after oral primary immunization. After parenteral reimmunization, 45% of ASCs were alpha(4)beta(7) positive and 79% were L-selectin positive, similar to the results after parenteral primary immunization. The route of priming had no effect on HR patterns in either case.
CONCLUSIONS: Homing potentials of lymphocytes depend on the site of antigen reencounter. Whereas the HR profile after parenteral reimmunization resembles that after primary immunization, the profile after oral reimmunization is uniquely characterized by high expression of both HRs, suggesting gut-localized memory and effective homing ability to both the mucosal and systemic immune system. These data may prove valuable in the search for the most effective immunization route in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15609243     DOI: 10.1086/426943

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut.

Authors:  S W Lin; A S Cun; K Harris-McCoy; H C Ertl
Journal:  Vaccine       Date:  2006-12-06       Impact factor: 3.641

Review 2.  Role of retinoic acid in the imprinting of gut-homing IgA-secreting cells.

Authors:  J Rodrigo Mora; Ulrich H von Andrian
Journal:  Semin Immunol       Date:  2008-09-18       Impact factor: 11.130

Review 3.  Enteric infections, diarrhea, and their impact on function and development.

Authors:  William A Petri; Mark Miller; Henry J Binder; Myron M Levine; Rebecca Dillingham; Richard L Guerrant
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

4.  Differential patterns of endothelial and leucocyte activation in 'typhus-like' illnesses in Laos and Thailand.

Authors:  D H Paris; K Jenjaroen; S D Blacksell; R Phetsouvanh; V Wuthiekanun; P N Newton; N P J Day; G D H Turner
Journal:  Clin Exp Immunol       Date:  2008-05-23       Impact factor: 4.330

5.  Humoral immune response to keyhole limpet haemocyanin, the protein carrier in cancer vaccines.

Authors:  A Kantele; M P Häkkinen; J Zivny; C O Elson; J Mestecky; J M Kantele
Journal:  Clin Dev Immunol       Date:  2011-06-12

6.  Differences in Homing Potentials of Streptococcus pneumoniae-Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations.

Authors:  Nina V Palkola; Sari H Pakkanen; Jussi M Kantele; Laura Pakarinen; Ritvaleena Puohiniemi; Anu Kantele
Journal:  J Infect Dis       Date:  2015-04-02       Impact factor: 5.226

7.  Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial.

Authors:  Anu Kantele; Sari H Pakkanen; Riitta Karttunen; Jussi M Kantele
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.